Global Huntington’s Disease Treatment Market Size study, by Treatment (Symptomatic treatment, Disease-modifying therapies) and Regional Forecasts 2022-2028
- BIZ4983094
- 200 Pages
- June 2022
- Pharmaceuticals
The key regions considered for the Global Huntington’s Disease Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. The Huntington's disease treatment market in North America had the biggest revenue share. This increase is attributable to the disease's high burden, rising healthcare costs, technology improvements, proactive government actions, and improved patient awareness of Huntington's disease treatment options. H. Lundbeck A/S and Teva Pharmaceutical Industries Ltd., for example, are supporting market expansion by introducing symptom control medicines. Due to increased product penetration, untapped potential, and the growing prevalence of the condition in emerging nations, the market for Huntington's disease therapy in Asia Pacific is predicted to rise at a substantial CAGR over the forecast period. The market in the region is predicted to increase as a result of an increasing number of government initiatives aimed at improving the population's health.
Major market player included in this report are:
H. Lundbeck A/S
Teva Pharmaceutical Industries Ltd.
Bausch Health Companies Inc.
Hetero
Lupin
Hikma Pharmaceuticals PLC
Dr. Reddy’s Laboratories Ltd.
Sun Pharmaceutical Industries Ltd.
Valeant Pharmaceuticals International Inc
Alnylam Pharmaceuticals Inc.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Treatment
Symptomatic treatment
Disease-modifying therapies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Huntington’s Disease Treatment Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
1.2.1. Huntington’s Disease Treatment Market, by Region, 2020-2028 (USD Million)
1.2.2. Huntington’s Disease Treatment Market, by Treatment, 2020-2028 (USD Million)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Huntington’s Disease Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Huntington’s Disease Treatment Market Dynamics
3.1. Huntington’s Disease Treatment Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Increased adoption of novel therapeutics
3.1.1.2. Rise in target population
3.1.2. Market Challenges
3.1.2.1. High cost associated with Drug Development
3.1.3. Market Opportunities
3.1.3.1. Increase in R&D activities
3.1.3.2. Favourable government initiatives
Chapter 4. Global Huntington’s Disease Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
Chapter 5. Risk Assessment: COVID-19 Impact
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 market scenario
Chapter 6. Global Huntington’s Disease Treatment Market, by Treatment
6.1. Market Snapshot
6.2. Global Huntington’s Disease Treatment Market by Treatment, Performance - Potential Analysis
6.3. Global Huntington’s Disease Treatment Market Estimates & Forecasts by Treatment 2018-2028 (USD Million)
6.4. Huntington’s Disease Treatment Market, Sub Segment Analysis
6.4.1. Symptomatic treatment
6.4.2. Disease-modifying therapies
Chapter 7. Global Huntington’s Disease Treatment Market, Regional Analysis
7.1. Huntington’s Disease Treatment Market, Regional Market Snapshot
7.2. North America Huntington’s Disease Treatment Market
7.2.1. U.S. Huntington’s Disease Treatment Market
7.2.1.1. Treatment breakdown estimates & forecasts, 2018-2028
7.2.2. Canada Huntington’s Disease Treatment Market
7.3. Europe Huntington’s Disease Treatment Market Snapshot
7.3.1. U.K. Huntington’s Disease Treatment Market
7.3.2. Germany Huntington’s Disease Treatment Market
7.3.3. France Huntington’s Disease Treatment Market
7.3.4. Spain Huntington’s Disease Treatment Market
7.3.5. Italy Huntington’s Disease Treatment Market
7.3.6. Rest of Europe Huntington’s Disease Treatment Market
7.4. Asia-Pacific Huntington’s Disease Treatment Market Snapshot
7.4.1. China Huntington’s Disease Treatment Market
7.4.2. India Huntington’s Disease Treatment Market
7.4.3. Japan Huntington’s Disease Treatment Market
7.4.4. Australia Huntington’s Disease Treatment Market
7.4.5. South Korea Huntington’s Disease Treatment Market
7.4.6. Rest of Asia Pacific Huntington’s Disease Treatment Market
7.5. Latin America Huntington’s Disease Treatment Market Snapshot
7.5.1. Brazil Huntington’s Disease Treatment Market
7.5.2. Mexico Huntington’s Disease Treatment Market
7.6. Rest of The World Huntington’s Disease Treatment Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. H. Lundbeck A/S
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Teva Pharmaceutical Industries Ltd.
8.2.3. Bausch Health Companies Inc.
8.2.4. Hetero
8.2.5. Lupin
8.2.6. Hikma Pharmaceuticals PLC
8.2.7. Dr. Reddy’s Laboratories Ltd.
8.2.8. Sun Pharmaceutical Industries Ltd.
8.2.9. Valeant Pharmaceuticals International Inc
8.2.10. Alnylam Pharmaceuticals Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
TABLE 1. Global Huntington’s Disease Treatment Market, report scope
TABLE 2. Global Huntington’s Disease Treatment Market estimates & forecasts by Region 2018-2028 (USD Million)
TABLE 3. Global Huntington’s Disease Treatment Market estimates & forecasts by Treatment 2018-2028 (USD Million)
TABLE 4. Global Huntington’s Disease Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 5. Global Huntington’s Disease Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 6. Global Huntington’s Disease Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 7. Global Huntington’s Disease Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 8. Global Huntington’s Disease Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 9. Global Huntington’s Disease Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 10. Global Huntington’s Disease Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 11. Global Huntington’s Disease Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 12. Global Huntington’s Disease Treatment Market by segment, estimates & forecasts, 2018-2028 (USD Million)
TABLE 13. Global Huntington’s Disease Treatment Market by region, estimates & forecasts, 2018-2028 (USD Million)
TABLE 14. U.S. Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 15. U.S. Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 16. U.S. Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 17. Canada Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 18. Canada Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 19. Canada Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 20. UK Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 21. UK Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 22. UK Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 23. Germany Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 24. Germany Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 25. Germany Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 26. RoE Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 27. RoE Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 28. RoE Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 29. China Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 30. China Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 31. China Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 32. India Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 33. India Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 34. India Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 35. Japan Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 36. Japan Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 37. Japan Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 38. RoAPAC Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 39. RoAPAC Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 40. RoAPAC Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 41. Brazil Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 42. Brazil Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 43. Brazil Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 44. Mexico Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 45. Mexico Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 46. Mexico Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 47. RoLA Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 48. RoLA Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 49. RoLA Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 50. Row Huntington’s Disease Treatment Market estimates & forecasts, 2018-2028 (USD Million)
TABLE 51. Row Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 52. Row Huntington’s Disease Treatment Market estimates & forecasts by segment 2018-2028 (USD Million)
TABLE 53. List of secondary sources, used in the study of global Huntington’s Disease Treatment Market
TABLE 54. List of primary sources, used in the study of global Huntington’s Disease Treatment Market
TABLE 55. Years considered for the study
TABLE 56. Exchange rates considered
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
